Colony Group LLC Grifols Sa Transaction History

Colony Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 18, 2021	SELL	$16.62 - $18.94 $317,840 - $362,208	-19,124 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$15.15 - $19.78 $98,944 - $129,183	6,531 Added 51.86%	19,124 $331,000
Q4 2020 Feb 16, 2021	SELL	$16.86 - $19.67 $15,764 - $18,391	-935 Reduced 6.91%	12,593 $232,000
Q3 2020 Nov 17, 2020	BUY	$15.4 - $20.16 $49,880 - $65,298	3,239 Added 31.48%	13,528 $235,000
Q2 2020 Aug 13, 2020	BUY	$18.24 - $21.45 $187,671 - $220,699	10,289 New	10,289 $188,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

Stay updated on Colony Group LLC with notifications on news.